Literature DB >> 21709191

Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?

Fabrizio Carnevale-Schianca1, Susanna Gallo, Delia Rota-Scalabrini, Dario Sangiolo, Marco Fizzotti, Daniela Caravelli, Antonio Capaldi, Giancarlo Anselmetti, Erica Palesandro, Lorenzo D'Ambrosio, Valentina Coha, Remo Obert, Massimo Aglietta, Giovanni Grignani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21709191     DOI： 10.1200/JCO.2011.35.6733

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  21 in total

Review 1.  Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.

Authors:  Dakota Gustafson; Jason E Fish; Jeffrey H Lipton; Nazanin Aghel
Journal:  Curr Hematol Malig Rep       Date:  2020-02       Impact factor: 3.952

2.  Imatinib Treatment for Bleomycin-Induced Pulmonary Toxicity.

Authors:  Nilüfer Aykaç; Coşkun Tecimer
Journal:  Turk Thorac J       Date:  2020-11-01

3.  Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury.

Authors:  Alicia N Rizzo; Saad Sammani; Adilene E Esquinca; Jeffrey R Jacobson; Joe G N Garcia; Eleftheria Letsiou; Steven M Dudek
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 4.  Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.

Authors:  Alicia N Rizzo; Jurjan Aman; Geerten P van Nieuw Amerongen; Steven M Dudek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-26       Impact factor: 8.311

Review 5.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

Review 6.  Using cultured endothelial cells to study endothelial barrier dysfunction: Challenges and opportunities.

Authors:  Jurjan Aman; Ester M Weijers; Geerten P van Nieuw Amerongen; Asrar B Malik; Victor W M van Hinsbergh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-24       Impact factor: 5.464

7.  The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy.

Authors:  Takeshi Kinjo; Koji Tomaru; Diana C Haines; Dennis M Klinman
Journal:  Respir Res       Date:  2012-06-18

8.  Arg mediates LPS-induced disruption of the pulmonary endothelial barrier.

Authors:  Alicia N Rizzo; Patrick Belvitch; Regaina Demeritte; Joe G N Garcia; Eleftheria Letsiou; Steven M Dudek
Journal:  Vascul Pharmacol       Date:  2020-03-30       Impact factor: 5.773

9.  Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.

Authors:  Jurjan Aman; Erik Duijvelaar; Liza Botros; Azar Kianzad; Job R Schippers; Patrick J Smeele; Sara Azhang; Imke H Bartelink; Ahmed A Bayoumy; Pierre M Bet; Wim Boersma; Peter I Bonta; Karin A T Boomars; Lieuwe D J Bos; Job J M H van Bragt; Gert-Jan Braunstahl; Lucas R Celant; Katrien A B Eger; J J Miranda Geelhoed; Yurika L E van Glabbeek; Hans P Grotjohan; Laura A Hagens; Chris M Happe; Boaz D Hazes; Leo M A Heunks; Michel van den Heuvel; Wouter Hoefsloot; Rianne J A Hoek; Romke Hoekstra; Herman M A Hofstee; Nicole P Juffermans; E Marleen Kemper; Renate Kos; Peter W A Kunst; Ariana Lammers; Ivo van der Lee; E Laurien van der Lee; Anke-Hilse Maitland-van der Zee; Pearl F M Mau Asam; Adinda Mieras; Mirte Muller; Liesbeth Neefjes; Esther J Nossent; Laurien M A Oswald; Maria J Overbeek; Carolina Pamplona; Nienke Paternotte; Niels Pronk; Michiel A de Raaf; Bas F M van Raaij; Merlijn Reijrink; Marcus J Schultz; Ary Serpa Neto; Elise M Slob; Frank W J M Smeenk; Marry R Smit; A Josien Smits; Janneke E Stalenhoef; Pieter R Tuinman; Arthur L E M Vanhove; Jessie N Wessels; Jessie C C van Wezenbeek; Anton Vonk Noordegraaf; Frances S de Man; Harm J Bogaard
Journal:  Lancet Respir Med       Date:  2021-06-17       Impact factor: 30.700

10.  FELD better not thinking of metastases only when liver lesions appear after bleomycin-based treatment for non-seminoma testis from metastases.

Authors:  Filip Y F L De Vos; Sasja F Mulder; Joost P H Drenth; Iris D Nagtegaal; Jurgen J Fütterer; Winette T A van der Graaf
Journal:  BMC Cancer       Date:  2013-10-22       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.